NCT03235505View on ClinicalTrials.gov

Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers

PHASE4CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Smoking CessationElectronic Cigarette
Interventions
DRUG

Varenicline Tartrate

Varenicline + Innokin Endura T20S electronic inhaler but without any nicotine content + MI

BEHAVIORAL

Motivational Interview

Placebo-varenicline + Innokin ENdura T20S electronic inhaler but without any nicotine content +MI

DRUG

Nicotine

Nicotine containing e-cigarettes + placebo-varenicline + Motivational Interview (MI)

Trial Locations (1)

96440

Lapland Central Hospital, Rovaniemi

All Listed Sponsors
collaborator

Lapland Central Hospital Rovaniemi Finland

UNKNOWN

lead

University of Oulu

OTHER

NCT03235505 - Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers | Biotech Hunter | Biotech Hunter